Peptoids successfully inhibit the growth of gram negative E. coli causing substantial membrane damage

Scientific Reports

Volumn 7, Issue , 2017, Pages

  Mojsoska, Biljana ^a   Carretero, Gustavo ^a,b   Larsen, Sylvester ^a,c   Mateiu, Ramona Valentina ^d   Jenssen, Håvard ^a  

^a ROSKILDE UNIVERSITY   (Denmark)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c NAESTVED HOSPITAL   (Denmark)

^d TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

6-CARBOXYFLUORESCEIN; ANTIINFECTIVE AGENT; BACTERIAL DNA; CALCEIN; FLUORESCEIN DERIVATIVE; FLUORESCENT DYE; LIPOSOME; PEPTOID;

CELL MEMBRANE; CELL MEMBRANE PERMEABILITY; CHEMISTRY; CYTOLOGY; DRUG EFFECT; ESCHERICHIA COLI; GROWTH, DEVELOPMENT AND AGING; KINETICS; METABOLISM; MICROBIAL SENSITIVITY TEST; MICROBIAL VIABILITY; ULTRASTRUCTURE;

ANTI-BACTERIAL AGENTS; CELL MEMBRANE; CELL MEMBRANE PERMEABILITY; DNA, BACTERIAL; ESCHERICHIA COLI; FLUORESCEINS; FLUORESCENT DYES; KINETICS; LIPOSOMES; MICROBIAL SENSITIVITY TESTS; MICROBIAL VIABILITY; PEPTOIDS;

EID: 85012927469     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep42332     Document Type: Article

References (59)

1. WHO. Antimicrobial resistance: overview of global report surveillance. (World Health Organization) (2014).
2. Outterson, K., Powers, J. H., Daniel, G. W. & McClellan, M. B. Repairing the broken market for antibiotic innovation. Health Aff (Millwood) 34, 277-285, doi: 10. 1377/hlthaff. 2014. 1003 (2015).
3. Jenssen, H., Hamill, P. & Hancock, R. E. W. Peptide antimicrobial agents. Clinical microbiology reviews 19, 491, doi: 10. 1128/ Cmr. 00056-05 (2006).
4. Mojsoska, B. & Jenssen, H. Peptides and Peptidomimetics for Antimicrobial Drug Design. Pharmaceuticals (Basel) 8, 366-415, doi: 10. 3390/ph8030366 (2015).
5. Hilpert, K. et al. Screening and characterization of surface-tethered cationic peptides for antimicrobial activity. Chemistry & biology 16, 58-69, doi: 10. 1016/j. chembiol. 2008. 11. 006 (2009).
6. Miller, S. M. et al. Proteolytic studies of homologous peptide and N-substituted glycine peptoid oligomers. Bioorganic & medicinal chemistry letters 4, 2657-2662, doi: http://dx. doi. org/10. 1016/S0960-894X(01)80691-0 (1994).
7. Simon, R. J. et al. Peptoids: A modular approach to drug discovery. Proceedings of the National Academy of Sciences of the United States of America 89, 9367-9371 (1992).
8. Chongsiriwatana, N. P. et al. Peptoids that mimic the structure, function, and mechanism of helical antimicrobial peptides. Proceedings of the National Academy of Sciences of the United States of America 105, 2794-2799, doi: 10. 1073/pnas. 0708254105 (2008).
9. Czyzewski, A. M. et al. In Vivo, In Vitro, and In Silico Characterization of Peptoids as Antimicrobial Agents. PloS one 11, e0135961, doi: 10. 1371/journal. pone. 0135961 (2016).
10. Godballe, T., Nilsson, L. L., Petersen, P. D. & Jenssen, H. Antimicrobial beta-peptides and alpha-peptoids. Chemical biology & drug design 77, 107-116, doi: 10. 1111/j. 1747-0285. 2010. 01067. x (2011).
11. Tan, N. C., Yu, P., Kwon, Y. U. & Kodadek, T. High-throughput evaluation of relative cell permeability between peptoids and peptides. Bioorganic & medicinal chemistry 16, 5853-5861, doi: 10. 1016/j. bmc. 2008. 04. 074 (2008).
12. Mojsoska, B., Zuckermann, R. N. & Jenssen, H. Structure-activity relationship study of novel peptoids that mimic the structure of antimicrobial peptides. Antimicrobial agents and chemotherapy 59, 4112-4120, doi: 10. 1128/AAC. 00237-15 (2015).
13. Smith, P. T., Huang, M. L. & Kirshenbaum, K. Osmoprotective polymer additives attenuate the membrane pore-forming activity of antimicrobial peptoids. Biopolymers 103, 227-236, doi: 10. 1002/bip. 22588 (2015).
14. Murphy, J. E. et al. A combinatorial approach to the discovery of efficient cationic peptoid reagents for gene delivery. Proceedings of the National Academy of Sciences of the United States of America 95, 1517-1522 (1998).
15. Goodson, B. et al. Characterization of novel antimicrobial peptoids. Antimicrobial agents and chemotherapy 43, 1429-1434 (1999).
16. Godballe, T., Mojsoska, B., Nielsen, H. M. & Jenssen, H. Antimicrobial activity of GN peptides and their mode of action. Biopolymers, doi: 10. 1002/bip. 22796 (2015).
17. Bang, J. K., Nan, Y. H., Lee, E. K. & Shin, S. Y. A Novel Trp-rich Model Antimicrobial Peptoid with Increased Protease Stability. B Korean Chem Soc 31, 2509-2513, doi: 10. 5012/bkcs. 2010. 31. 9. 2509 (2010).
18. Ganz, T. Defensins: Antimicrobial peptides of innate immunity. Nature reviews. Immunology 3, 710-720, doi: 10. 1038/nri1180 (2003).
19. Jindal, H. M. et al. Antimicrobial Activity of Novel Synthetic Peptides Derived from Indolicidin and Ranalexin against Streptococcus pneumoniae. PloS one 10, e0128532, doi: 10. 1371/journal. pone. 0128532 (2015).
20. Hawkey, P. M. Mechanisms of quinolone action and microbial response. The Journal of antimicrobial chemotherapy 51 Suppl 1, 29-35, doi: 10. 1093/jac/dkg207 (2003).
21. Takahashi, H., Palermo, E. F., Yasuhara, K., Caputo, G. A. & Kuroda, K. Molecular design, structures, and activity of antimicrobial peptide-mimetic polymers. Macromolecular bioscience 13, 1285-1299, doi: 10. 1002/mabi. 201300126 (2013).
22. Jahnsen, R. D., Haney, E. F., Franzyk, H. & Hancock, R. E. Characterization of a proteolytically stable multifunctional host defense peptidomimetic. Chemistry & biology 20, 1286-1295, doi: 10. 1016/j. chembiol. 2013. 09. 007 (2013).
23. Hein-Kristensen, L., Knapp, K. M., Franzyk, H. & Gram, L. Bacterial membrane activity of alpha-peptide/beta-peptoid chimeras: influence of amino acid composition and chain length on the activity against different bacterial strains. BMC microbiology 11, 144, doi: 10. 1186/1471-2180-11-144 (2011).
24. Fisher, L. M. et al. Ciprofloxacin and the fluoroquinolones. New concepts on the mechanism of action and resistance. The American journal of medicine 87, 2S-8S (1989).
25. HsuChen, C. C. & Feingold, D. S. The mechanism of polymyxin B action and selectivity toward biologic membranes. Biochemistry 12, 2105-2111 (1973).
26. Tossi, A., Sandri, L. & Giangaspero, A. Amphipathic, alpha-helical antimicrobial peptides. Biopolymers 55, 4-30, doi: 10. 1002/1097-0282(2000)55:1> 4::AID-BIP30< 3. 0. CO;2-M (2000).
27. Tiozzo, E., Rocco, G., Tossi, A. & Romeo, D. Wide-spectrum antibiotic activity of synthetic, amphipathic peptides. Biochemical and biophysical research communications 249, 202-206, doi: 10. 1006/bbrc. 1998. 9114 (1998).
28. Smith, P. T., Huang, M. L. & Kirshenbaum, K. Osmoprotective Polymer Additives Attenuate the Membrane Pore-Forming Activity of Antimicrobial Peptoids. Biopolymers, doi: 10. 1002/bip. 22588 (2014).
29. Zasloff, M. Antimicrobial peptides of multicellular organisms. Nature 415, 389-395, doi: 10. 1038/415389a (2002).
30. Ramamoorthy, A. et al. Cell selectivity correlates with membrane-specific interactions: A case study on the antimicrobial peptide G15 derived from granulysin. Biochimica et biophysica acta 1758, 154-163, doi: 10. 1016/j. bbamem. 2006. 02. 014 (2006).
31. Bera, S. et al. Biophysical insights into the membrane interaction of the core amyloid-forming Abeta40 fragment K16-K28 and its role in the pathogenesis of Alzheimer's disease. Physical chemistry chemical physics: PCCP 18, 16890-16901, doi: 10. 1039/ c6cp02023b (2016).
32. Sengupta, D., Leontiadou, H., Mark, A. E. & Marrink, S. J. Toroidal pores formed by antimicrobial peptides show significant disorder. Biochimica et biophysica acta 1778, 2308-2317, doi: 10. 1016/j. bbamem. 2008. 06. 007 (2008).
33. Saravanan, R. et al. Design of short membrane selective antimicrobial peptides containing tryptophan and arginine residues for improved activity, salt-resistance, and biocompatibility. Biotechnology and bioengineering 111, 37-49, doi: 10. 1002/bit. 25003 (2014).
34. Subbalakshmi, C. & Sitaram, N. Mechanism of antimicrobial action of indolicidin. FEMS microbiology letters 160, 91-96 (1998).
35. Rokitskaya, T. I., Kolodkin, N. I., Kotova, E. A. & Antonenko, Y. N. Indolicidin action on membrane permeability: carrier mechanism versus pore formation. Biochimica et biophysica acta 1808, 91-97, doi: 10. 1016/j. bbamem. 2010. 09. 005 (2011).
36. Fjell, C. D., Hiss, J. A., Hancock, R. E. & Schneider, G. Designing antimicrobial peptides: form follows function. Nature reviews. Drug discovery 11, 37-51, doi: 10. 1038/nrd3591 (2012).
37. Huang, H. W. Molecular mechanism of antimicrobial peptides: The origin of cooperativity. Biochimica et biophysica acta 1758, 1292-1302, doi: 10. 1016/j. bbamem. 2006. 02. 001 (2006).
38. Russell, A. L. et al. Spectroscopic and thermodynamic evidence for antimicrobial peptide membrane selectivity. Chemistry and physics of lipids 163, 488-497, doi: 10. 1016/j. chemphyslip. 2010. 03. 009 (2010).
39. Neale, C., Hsu, J. C., Yip, C. M. & Pomes, R. Indolicidin binding induces thinning of a lipid bilayer. Biophysical journal 106, L29-31, doi: 10. 1016/j. bpj. 2014. 02. 031 (2014).
40. Lundquist, A., Wessman, P., Rennie, A. R. & Edwards, K. Melittin-lipid interaction: A comparative study using liposomes, micelles and bilayer disks. Biochimica et biophysica acta 1778, 2210-2216, doi: 10. 1016/j. bbamem. 2008. 05. 009 (2008).
41. Killian, J. A. & von Heijne, G. How proteins adapt to a membrane-water interface. Trends in biochemical sciences 25, 429-434 (2000).
42. Arakha, M., Saleem, M., Mallick, B. C. & Jha, S. The effects of interfacial potential on antimicrobial propensity of ZnO nanoparticle. Sci Rep 5, 9578, doi: 10. 1038/srep09578 (2015).
43. Chileveru, H. R. et al. Visualizing attack of Escherichia coli by the antimicrobial peptide human defensin 5. Biochemistry 54, 1767-1777, doi: 10. 1021/bi501483q (2015).
44. Hartmann, M. et al. Damage of the bacterial cell envelope by antimicrobial peptides gramicidin S and PGLa as revealed by transmission and scanning electron microscopy. Antimicrobial agents and chemotherapy 54, 3132-3142, doi: 10. 1128/AAC. 00124-10 (2010).
45. Spratt, B. G. Distinct penicillin binding proteins involved in the division, elongation, and shape of Escherichia coli K12. Proceedings of the National Academy of Sciences of the United States of America 72, 2999-3003 (1975).
46. Mason, D. J., Power, E. G., Talsania, H., Phillips, I. & Gant, V. A. Antibacterial action of ciprofloxacin. Antimicrobial agents and chemotherapy 39, 2752-2758 (1995).
47. Lewin, C. S. & Amyes, S. G. The role of the SOS response in bacteria exposed to zidovudine or trimethoprim. J Med Microbiol 34, 329-332, doi: 10. 1099/00222615-34-6-329 (1991).
48. Lutkenhaus, J. Regulation of cell division in E. coli. Trends in genetics: TIG 6, 22-25 (1990).
49. Gottfredsson, M., Erlendsdottir, H., Sigfusson, A. & Gudmundsson, S. Characteristics and dynamics of bacterial populations during postantibiotic effect determined by flow cytometry. Antimicrobial agents and chemotherapy 42, 1005-1011 (1998).
50. Phillips, I., Culebras, E., Moreno, F. & Baquero, F. Induction of the SOS response by new 4-quinolones. The Journal of antimicrobial chemotherapy 20, 631-638 (1987).
51. Mukherjee, A., Cao, C. & Lutkenhaus, J. Inhibition of FtsZ polymerization by SulA, an inhibitor of septation in Escherichia coli. Proceedings of the National Academy of Sciences of the United States of America 95, 2885-2890 (1998).
52. Piddock, L. J. & Walters, R. N. Bactericidal activities of five quinolones for Escherichia coli strains with mutations in genes encoding the SOS response or cell division. Antimicrobial agents and chemotherapy 36, 819-825 (1992).
53. Wickens, H. J., Pinney, R. J., Mason, D. J. & Gant, V. A. Flow cytometric investigation of filamentation, membrane patency, and membrane potential in Escherichia coli following ciprofloxacin exposure. Antimicrobial agents and chemotherapy 44, 682-687 (2000).
54. Tamayo, M., Santiso, R., Gosalvez, J., Bou, G. & Fernandez, J. L. Rapid assessment of the effect of ciprofloxacin on chromosomal DNA from Escherichia coli using an in situ DNA fragmentation assay. BMC microbiology 9, 69, doi: 10. 1186/1471-2180-9-69 (2009).
55. Novo, D. J., Perlmutter, N. G., Hunt, R. H. & Shapiro, H. M. Multiparameter flow cytometric analysis of antibiotic effects on membrane potential, membrane permeability, and bacterial counts of Staphylococcus aureus and Micrococcus luteus. Antimicrobial agents and chemotherapy 44, 827-834 (2000).
56. Hale, J. D. & Hancock, R. E. Alternative mechanisms of action of cationic antimicrobial peptides on bacteria. Expert review of antiinfective therapy 5, 951-959, doi: 10. 1586/14787210. 5. 6. 951 (2007).
57. Fjell, C. D. et al. Identification of novel antibacterial peptides by chemoinformatics and machine learning. Journal of medicinal chemistry 52, 2006-2015, doi: 10. 1021/jm8015365 (2009).
58. Rouser, G., Fkeischer, S. & Yamamoto, A. Two dimensional then layer chromatographic separation of polar lipids and determination of phospholipids by phosphorus analysis of spots. Lipids 5, 494-496 (1970).
59. Alvarez, C. et al. Binding of sea anemone pore-forming toxins sticholysins I and II to interfaces-modulation of conformation and activity, and lipid-protein interaction. Chemistry and physics of lipids 122, 97-105 (2003).